GIANNATEMPO, PATRIZIA
 Distribuzione geografica
Continente #
NA - Nord America 104
EU - Europa 83
AS - Asia 21
AF - Africa 1
OC - Oceania 1
Totale 210
Nazione #
US - Stati Uniti d'America 104
IT - Italia 60
CN - Cina 10
IN - India 9
FR - Francia 5
GB - Regno Unito 5
CZ - Repubblica Ceca 2
IE - Irlanda 2
UA - Ucraina 2
AT - Austria 1
AU - Australia 1
CH - Svizzera 1
DE - Germania 1
FI - Finlandia 1
GR - Grecia 1
JP - Giappone 1
PL - Polonia 1
SE - Svezia 1
TR - Turchia 1
ZA - Sudafrica 1
Totale 210
Città #
Milan 39
Fairfield 14
Woodbridge 11
Houston 8
Ashburn 7
Bengaluru 6
Santa Cruz 6
Tappahannock 5
Buffalo 4
Seattle 4
Beijing 3
Cambridge 3
Londonderry 3
Milpitas 3
Southend 3
Boardman 2
Dublin 2
Rome 2
San Diego 2
Tianjin 2
Wuhan 2
Ancona 1
Ann Arbor 1
Avezzano 1
Bangalore 1
Boulder 1
Chennai 1
Chicago 1
Fleming Island 1
Florence 1
Hangzhou 1
Helsinki 1
Innsbruck 1
Ipswich 1
Kenmore 1
London 1
Los Angeles 1
Miami 1
Muizenberg 1
Nettuno 1
New Delhi 1
Polska 1
Rescaldina 1
Reston 1
Riva 1
Salem 1
San Francisco 1
Shanghai 1
Stoneham 1
Sydney 1
Takamatsu 1
Taranto 1
Zurich 1
Totale 163
Nome #
Corrigendum to “Recommendations for surveillance and follow-up of men with testicular germ cell tumors: A multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica” (Critical Reviews in Oncology / Hematology (2019) 137 (154–164), (S1040842819300587), (10.1016/j.critrevonc.2019.03.006)), file dfa8b9a2-cf2e-748b-e053-3a05fe0a3a96 143
Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma, file dfa8b99e-6f7a-748b-e053-3a05fe0a3a96 33
Prognostic reclassification of patients with intermediate-risk metastatic germ cell tumors : implications for clinical practice, trial design, and molecular interrogation, file dfa8b995-e448-748b-e053-3a05fe0a3a96 10
Radiotherapy or chemotherapy for clinical stage IIA and IIB seminoma : a systematic review and meta-analysis of patient outcomes, file dfa8b995-d42d-748b-e053-3a05fe0a3a96 7
PF-03446962, a fully-human monoclonal antibody against transforming growth-factor β (TGFβ) receptor ALK1, in pre-treated patients with urothelial cancer : an open label, single-group, phase 2 trial, file dfa8b995-b1de-748b-e053-3a05fe0a3a96 5
Immunohistochemistry to enhance prognostic allocation and guide decision-making of patients with advanced urothelial cancer receiving first-line chemotherapy, file dfa8b995-de6a-748b-e053-3a05fe0a3a96 5
Clinical experience with temsirolimus in the treatment of advanced renal cell carcinoma, file dfa8b995-af80-748b-e053-3a05fe0a3a96 4
Pazopanib in advanced and platinum-resistant urothelial cancer: an open-label, single group, phase 2 trial, file dfa8b992-b078-748b-e053-3a05fe0a3a96 3
An open-label, single-arm, phase 2 study of the Aurora kinase A inhibitor alisertib in patients with advanced urothelial cancer, file dfa8b996-722d-748b-e053-3a05fe0a3a96 2
Molecular Signature of Response to Pazopanib Salvage Therapy for Urothelial Carcinoma, file dfa8b99e-2658-748b-e053-3a05fe0a3a96 1
Biomarker-driven immunotherapy for precision medicine in prostate cancer, file dfa8b9a9-d53c-748b-e053-3a05fe0a3a96 1
Totale 214
Categoria #
all - tutte 486
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 486


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191 0 0 0 0 0 0 0 0 0 0 1 0
2019/20208 1 0 2 0 0 1 0 0 3 0 0 1
2020/202161 5 3 4 1 16 9 5 3 5 7 2 1
2021/202248 2 1 4 6 3 4 3 3 3 3 11 5
2022/202338 1 6 6 6 4 2 4 2 1 2 4 0
2023/202423 2 2 3 1 7 3 0 5 0 0 0 0
Totale 214